Cardiac and Inflammatory Biomarker Differences in Adverse Cardiac Events after Chimeric Antigen Receptor T-Cell Therapy: an Exploratory Study
Cardio-oncology(2023)
摘要
Chimeric antigen receptor T- Cell (CAR-T) immunotherapy has been a breakthrough treatment for various hematological malignancies. However, cardiotoxicities such as new-onset heart failure, arrhythmia, acute coronary syndrome and cardiovascular death occur in 10–15
更多查看译文
关键词
Chimeric antigen receptor T cell,Cardiotoxicity,Cardio-oncology,Cardiac biomarker,Tocilizumab,Inflammatory cytokines
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要